4//SEC Filing
Sliman Joseph A. 4
Accession 0001144204-17-064829
CIK 0000894158other
Filed
Dec 20, 7:00 PM ET
Accepted
Dec 21, 5:20 PM ET
Size
5.6 KB
Accession
0001144204-17-064829
Insider Transaction Report
Form 4
Sliman Joseph A.
Chief Medical Officer
Transactions
- Award
Stock Options
2017-12-20+410,000→ 410,000 totalExercise: $0.52From: 2017-12-20Exp: 2024-12-19→ Common Stock (410,000 underlying)
Footnotes (1)
- [F1]These options will vest monthly on a pro rata basis over 36 consecutive months.
Documents
Issuer
Synthetic Biologics, Inc.
CIK 0000894158
Entity typeother
Related Parties
1- filerCIK 0001694213
Filing Metadata
- Form type
- 4
- Filed
- Dec 20, 7:00 PM ET
- Accepted
- Dec 21, 5:20 PM ET
- Size
- 5.6 KB